hormonal contraceptive users should discuss timing with their provider, as lipotropic compounds may affect nutrient absorption
Clinical trials have demonstrated that rituximab can reduce proteinuria in patients with nephropathy and concurrent autoimmune disorders (146), correlating with decreased renal IL-6 and macrophage infiltration
Discuss whether GLP-1 therapy is appropriate for concurrent diabetes or obesity, potential drug interactions with DMARDs, realistic expectations about anti-inflammatory effects, and coordination between your rheumatology and endocrinology care teams
2) Use NovoCares assistance program
These clinical endpoints advocate for the therapeutic use of neurotrophic factors, which mediate neural development, neurogenesis, neuroprotection, and synaptogenesis